Protection studies against Marek's disease using baculovirus-expressed glycoproteins B and C of Marek's disease virus type 1

Avian Pathology

Volumn 25, Issue 1, 1996, Pages 5-24

  Jang, H K ^a   Kitazawa, T ^a   Ono, M ^a   Kawaguchi, Y ^a   Maeda, K ^a   Yokoyama, N ^a   Tohya, Y ^a   Niikura, M ^a,b   Mikami, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030055272     PISSN: 03079457     EISSN: None     Source Type: Journal    
DOI: 10.1080/03079459608419116     Document Type: Article

References (61)

1. BINNS, M.M. & ROSS, N.L.J. (1989). Nucleotide sequence of the Marek's disease virus (MDV) RB-1B A antigen gene and the identification of the MDV A antigen as the herpes simplex virus-1 glycoprotein C homologue. Virus Research, 12, 371-382.
2. BOURSNELL, M.E.G., GREEN, P.F., CAMPBELL, J.I.A., PEUTER, A., PETERS, R.W., TOMLEY, F.M., SAMSON, A.C.R., CHAMBER, P., EMMERSON, P.T. & BINNS, M.M. (1990). Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. Journal of General Virology, 71, 621-628.
3. BUCKMASTER, A., SCOTT, S.D., SANDERSON, M.J., BOURSNELL, M.G., ROSS, N.J. & BINNS, M.M. (1988). Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. Journal of General Virology, 69, 2033-2042.
4. CAI, W., GU, B. & PERSON, B. (1988). Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. Journal of Virology, 62, 2596-2604.
5. CANTIN, E.M., EBERLE, R., BALDICK, J.L., MOSS, B., WILLEY, D.E., NOTKINS, A.L. & OPENSHAW, H. (1987). Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proceedings of the National Academy of Sciences of the United States of America, 84, 5908-5912.
6. CEBRIAN, J., KASCHKA-DIERICH, C., BERTHELOT, N. & SHELDRICK, P. (1982). Inverted repeat nucleotide sequences in the genomes of Marek's disease virus and the herpesvirus of the turkey. Proceedings of the National Academy of Sciences of the United States of America, 79, 555-558.
7. CHEN, Z. & VELICER, L.F. (1992). Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen. Journal of Virology, 66, 4390-4398.
8. CHURCHILL, A.E., CHUBB, R.C. & BAXENDALE, R.C. (1969). The attenuation, with loss of oncogenicity, of the herpes-type viruses of Marek's disease (strain HPRS-16) on passage in cell culture. Journal of General Virology, 4, 557-564.
9. COUSSENS, P.M. & VELICER, L.F. (1988). Structure and complete nucleotide sequence of the Marek's disease herpesvirus gp57-65 gene. Journal of Virology, 62, 2373-2379.
10. COUSSENS, P.M., WILSON, M.R., CAMP, H., ROTHL, H., ISFORT, R.J. & VELICER, L.F. (1990). Characterization of the gene encoding herpesvirus of turkeys gp57-65: comparison to Marek's disease virus gp57-65 and herpes simplex virus glycoprotein C. Virus Genes, 3, 291-307.
11. CRANAGE, M.P., KOUZARIDES, T., BANKIER, A.T., SATCHWELL, S., WESTON, K., TOMLINSON, P., BARRELL, B., HART, H., BELL, S.E., MINSON, A.C. & SMITH, G.L. (1986). Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal, 5, 3057-3063.
12. FITZPATRICK, D.R., ZAMB, T. & BABIUK, L. (1990). Expression of bovine herpesvirus type 1 glycoprotein gI in transfected bovine cells induces spontaneous fusion. Journal of General Virology, 71, 1215-1219.
13. FITZPATRICK, D.R., ZAMB, T., PARKER, M.D., HURK, S.D.L., BABIUK, L.A. & LAWMAN, M.J.P. (1988). Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. Journal of Virology, 62, 4239-1248.
14. FRIEDMAN, H.M., GLORIOSO, J.C., COHEN, G.H., HASTINGS, J.C., HARRS, S.L. & EISENBERG, R.J. (1986). Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC binding sites and demonstration of conserved C3b binding in low passage clinical isolates. Journal of Virology, 60, 475-482.
15. FUKUCHI, K., SUDO, M., TANAKA, A. & NONOYAMA, M. (1985). Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene. Journal of Virology, 53, 994-997.
16. FULLER, A.O. & SPEAR, P.G. (1987). Anti-glycoprotein D antibodies that permit absorption but block infection by herpes simplex virus 1 prevent viron cell fusion at the cell surface. Proceedings of the National Academy of Sciences of the United States of America, 84, 5454-5458.
17. GHIASI, H., KAIWAR, R., NESBURN, A.B., SLANINA, S. & WECHSLER, S.L. (1994). Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI); comparative protection against lethal challenge in mice. Journal of Virology, 68, 2118-2126.
18. GHIASI, H., KAIWAR, R., NESBURN, A.B. & WECHSLER, S.L. (1992). Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Research, 18, 291-302.
19. GLAUBIGER, C., NAZERIAN, K. & VELICER, L.F. (1983). Marek's disease herpesvirus. IV. Molecular characterization of Marek's disease herpesvirus A antigen. Journal of Virology, 45, 1228-1234.
20. GLORIOSO, J., KEES, U., KUMEL, G., KIRCHNER, H. & KRAMMER, P.H. (1985). Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1 specific memory cytotoxic T lymphocytes. Journal of Immunology, 135, 575-582.
21. GUO, P., GOEBEL, S., DAVIS, S., PERKUS, M.E., LANGUET, B., DESMETTRE, P., ALLEN, G. & PAOLETTI, E. (1989). Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals. Journal of Virology, 63, 4189-4198.
22. GUO, P., GOEBEL, S., PERKUS, M.E., TAILOR, J., NORTON, E., ALLEN, G., LANGUET, B., DESMETTRE, P. & PAOLETTI, E. (1990). Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoroteins gp13 and gp14 results in potentiated imunity. Journal of Virology, 64, 2399-2406.
23. HEROLD, B.C., WUDUNN, D., SOLTYS, N. & SPEAR, P.G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cell and in infectivity. Journal of Virology, 65, 1090-1098.
24. IGARASHI, T., TAKAHASHI, M., DONOVAN, J., JESSIP, J., SMITH, M., HIRAI, K., TANAKA, A. & NONOYAMA, M. (1987). Restriction enzyme map of herpesvirus of turkey DNA and its collinear relationship with Marek's disease virus DNA. Virology, 157, 351-358.
25. IHARA, T., KATO, A., UEDA, S., ISHIHAMA, A. & HIRAI, K. (1989). Comparison of the sequence of the secretory glycoprotein A (gA) gene in Md5 and BC-1 strains of Marek's disease virus type 1. Virus Genes, 3, 127-140.
26. IKUTA, K., UEDA, S., KATO, S. & HIRAI, K. (1984). Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. Journal of Virology, 49, 1014-1017.
27. ISFORT, R.J., KUNG, H-J. & VELICER, L.F. (1987). Identification of the gene encoding Marek's disease herpesvirus A antigen. Journal of Virology, 61, 2614-2620.
28. ISFORT, R.J., SITHOLE, I., KUNG, H-J. & VELICER, L.F. (1986a). Molecular characterization of Marek's disease herpesvirus B antigen. Journal of Virology, 59, 411-419.
29. ISFORT, R.J., STRINGER, R.A., KUNG, H-J. & VELICER, L.F. (1986b). Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein. Journal of Virology, 57, 464-474.
30. JOHNSON, D.C. & FEENSTRA, V. (1987). Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. Journal of Virology, 61, 2208-2216.
31. KATO, A., SATO, I., IHARA, T., UEDA, S., ISHIHAMA, A. & HIRAI, K. (1989). Homologies between herpesvirus of turkey and Marek's disease virus type-1 DNAs within two co-linearly arranged open reading frames, one encoding glycoprotein A. Gene, 84, 399-405.
32. KELLER, P.M., NEFF, B.J. & ELLIS, R.W. (1984). Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology, 52, 293-297.
33. KITAZAWA, T., ONO, M., MAEDA, K., KAWAGUCHI, Y., KAMIYA, N., NIIKURA, M. & MIKAMI, T. (1993). Nucleotide sequence of the glycoprotein C (gC) homologous gene of Marek's disease virus (MDV) serotype 2 and comparison of gC homologous genes among three serotypes of MDV. Journal of Veterinary Medical Science, 55, 985-990.
34. LONG, P.A., CLARK, J.L. & VELICER, L.F. (1975a). Marek's disease herpesviruses. II. Purification and further characterization of Marek's disease herpesvirus A antigen. Journal of Virology, 15, 1192-1201.
35. LONG, P.A., KAVEH-YAMINI, P. & VELICER, L.F. (1975b). Marek's disease herpesviruses. I. Production and preliminary characterization of Marek's disease herpesviruses A antigen. Journal of Virology, 15, 1182-1191.
36. LUDWIG, H. (1983). Bovine Herpesviruses: VIII. Immune response and other defense mechanisms, in: B. ROIZMAN (Ed.), The Herpesviruses, vol. 1, pp. 183-187 (Plenum Press, New York).
37. MARTIN, S., MOSS, B., BERMAN, B.T., LASKEY, L.A. & ROUSE, B.T. (1987). Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. Journal of Virology, 61, 726-734.
38. MARTIN, S. & ROUSE, B.T. (1987). The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex type 1 glycoprotein D: clearance of local infection. Journal of Immunology, 138, 3431-3437.
39. METTENLEITER, T.C., ZASK, L., ZUCKERMANN, F., SUGG, N., KERN, H. & BEN-PORAT, T. (1990). Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. Journal of Virology, 64, 278-286.
40. MURTHY, K.K. & CALNEK, B.W. (1979). Pathogenesis of Marek's disease: effect of immunization with inactivated viral and tumor-associated antigens. Infection and Immunity, 26, 547-553.
41. NAZERIAN, K., LEE, L.F., YANAGIDA, N. & OGAWA, R. (1992). Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. Journal of Virology, 66, 1409-1413.
42. NIIKURA, M., MATSUURA, Y., ENDOH, D., ONUMA, M. & MIKAMI, T. (1992). Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV. Journal of Virology, 66, 2631-2638.
43. NIIKURA, M., MATSUURA, Y., HATTORI, M., ONUMA, M. & MIKAMI, T. (1991). Expression of the A antigen (gp57-65) of Marek's disease virus by a recombinant baculovirus. Journal of General Virology, 72, 1099-1104.
44. NORRILD, B. (1985). Humoral response to herpes simplex virus infections, in: B. ROIZMAN & C. LOPEZ (Eds), The Herpesviruses, vol. 4, pp. 69-86. (Plenum Press, New York).
45. OKAZAKI, K., MATSUZAKI, T., SUGAHARA, Y., OKADA, J., HASEBE, M., IWAMURA, Y., OHNISHI, M., KANNO, T., SHIMIZU, M., HONDA, E. & KONO, Y. (1991). BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology, 181, 666-670.
46. OKAZAKI, W., PURCHASE, H.G. & BURMESTER, B.R. (1970). Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Diseases, 14, 413-429.
47. ONO, K., TAKASHIMA, M., ISHIKAWA, T., HAYASHI, M., YOSHIDA, I., KONOBE, T., IKUTA, K., NAKAJIMA, K., UEDA, S., KATO, S. & HIRAI, K. (1984). Partial protection against Marek's disease in chickens immunized with glycoproteins gB pruified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies. Avian Diseases, 29, 533-539.
48. ONO, M., KATSURAGI-IWANAGA, R., KITAZAWA, T., KAMIYA, N., HORIMOTO, T., NIIKURA, M. KAI, C., HIRAI, K. & MIKAMI, T. (1992). The restriction endonuclease map of Marek's disease virus (MDV) serotype 2 and collinear relationship among three serotypes of MDV. Virology, 191, 459-463.
49. ONUMA, M., MIKAMI, T. & HAYASHI, T.T.A. (1974). Properties of the common antigen associated with Marek's disease herpesvirus and turkey herpesvirus infection. Journal of National Cancer Institute, 52, 805-813.
50. PAYNE, L.N. (1982). Biology of Marek's disease virus and the herpesvirus of turkeys, in: B. ROIZMAN (Ed.), The Herpesviruses, vol. 1, pp. 347-431 (Plenum Press, New York).
51. PURCHASE, H.G., BURMESTER, B.R. & CUNNINGHAM, C.H. (1971). Pathogenicity and antigenicity of clones from strains of Marek's disease virus and the herpesvirus of turkeys. Infection and Immunity, 3, 295-303.
52. RAUH, I. & METTENLEITER, T.C. (1991). Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. Journal of Virology, 65, 5348-5356.
53. RIVIERE, M., TARTAGLIA, J., PERKUS, M.E., NORTON, E.K., BONGERMINO, C.M., LACOSTE, F., DURET, C., DESMETTRE, P. & PAOLETTI, E. (1992). Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. Journal of Virology, 66, 3424-3434.
54. ROSS, L.J.N., SANDERSON, M., SCOTT, S.D., BINNS, M.M., DOEL, T. & MILNE, B. (1989). Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. Journal of General Virology, 70, 1789-1804.
55. SPEAR, P.G. (1985). Glycoproteins specified by herpes simplex virus, in: B. ROIZMAN (Ed.), The Herpesviruses, vol. 3, pp. 315-356 (Plenum Press, New York).
56. SPEAR, P.G. (1993) Entry of alphaherpesviruses into cells. Seminars in Virology, 4, 167-180.
57. VAN ZAANE, D., BRINKHOF, J.M.A., WESTENBRINK, F. & GIELKENS, A.L.J. (1982). Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology, 121, 116-132.
58. WITTER, R.L., SILVA, R.F. & LEE, L.F. (1987). New serorype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristis. Avian Diseases, 31, 829-840.
59. YOSHIDA, S., LEE, L.F., YANAGIDA, N. & NAZERIAN, K. (1994). The Glycoprotein B genes of Marek's Disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses. Virology, 200, 484-493.
60. ZARING, J.M., MORAN, P.A., BURKE, R.L., PACHL, C., BERMAN, P.W. & LASKY, L.A. (1986). Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Journal of Immunology, 136, 4669-4673.
61. ZASK, L., METTENLEITER, T.C., SUGG, N. & BEN-PORAT, T. (1989). Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components. Journal of Virology, 63, 5475-5477.